Patent · US Active

Composition for promoting myogenesis, containing processed ginseng extract

US12233099B2 · kind B2 · utility

0Cited by
1References
2Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMay 24, 2019
Grant dateFeb 25, 2025
Priority date
Expiry dateJun 25, 2042

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K2236/51
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention relates to a composition for promoting myogenesis, containing, as an active ingredient, a processed ginseng extract in which a trace amount of a ginsenoside ingredient is increased. It has been ascertained that the processed ginseng extract promotes the differentiation of myoblasts into muscle and inhibits muscle atrophy caused by myostatin, which is a myogenesis inhibitory factor, and thus it is expected that a composition for preventing or treating muscle disorder-related diseases, having excellent effects, can be developed.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.